NRX Pharmaceuticals Chairman Jonathan Javitt's 2023 pay falls 28% to $630K

NRX Pharmaceuticals reports 2023 executive compensation

By ExecPay News

Published: September 5, 2024

NRX Pharmaceuticals reported fiscal year 2023 executive compensation information on September 5, 2024.
In 2023, three executives at NRX Pharmaceuticals received on average a compensation package of $476K, a 31% decrease compared to previous year.
Average pay of disclosed executives at NRX Pharmaceuticals
Jonathan Javitt, Chairman, received $630K in total, which decreased by 28% compared to 2022. 96% of Javitt's compensation, or $603K, was in salary. Javitt also received $27K in other compensation.
Stephen H. Willard, Chief Executive Officer, received a compensation package of $500K, which decreased by 37% compared to previous year. 100% of the compensation package, or $500K, was in salary.
Richard Narido, Chief Financial Officer, earned $298K in 2023.

Related executives

Stephen Willard

NRX Pharmaceuticals

Chief Executive Officer

Jonathan Javitt

NRX Pharmaceuticals

Chairman

Richard Narido

NRX Pharmaceuticals

Chief Financial Officer

You may also like

Source: SEC filing on September 5, 2024.